NTRP NextTrip, Inc.

NASDAQ
$1.34

NextTrip, Inc. (NTRP) is expected to report earnings on October 14, 2026, during market hours. The consensus earnings estimate is a loss of $0.24 per share, and the stock has had a Post-Earnings Announcement Drift (PEAD) of -34.9% since its last earnings release on July 15, 2026.

NextTrip Reported In-line with Estimates
Wednesday, July 15, 2026 · 12:00 AM ET
Earnings Date
2nd Quarter, Aug 2026
Oct 14
Wednesday · Market Hours
Earnings Whisper
-
vs ($0.24)
Rev est $1.44M
Volatility
Enter your expectations below to reveal the current volatility.
Trend Analysis
Expectation
Earnings
Price action
Signals
Score
Sentiment
Grade
Life Cycle
Call Analysis
Earnings-AVWAP $1.94

Sign in or subscribe to unlock sentiment, short interest, and technical indicators.

About NextTrip, Inc.

Neurotrope Inc is a development stage company. The Company is a clinical stage biopharmaceutical and diagnostics company, engaged in developing drug candidate called bryostatin and a diagnostic test for Alzheimer’s Disease.

Sector

Discretionary

Industry

Leisure & Recreation Services